Literature DB >> 1485890

Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells.

M Ebbecke1, C Unterberg, A Buchwald, S Stöhr, V Wiegand.   

Abstract

The effects of a c-myc antisense phosphorothioate DNA oligonucleotide were assessed on the proliferation rate of human arterial smooth muscle cells (HSMCs). Compared to a control oligonucleotide the antisense oligonucleotide suppressed the proliferation of HSMCs in a concentration-dependent manner without a major cytotoxic effect. Outgrowth of HSMCs from media explants was significantly inhibited as well. Induction of c-myc expression by serum stimulation of cells was blunted by the antisense oligonucleotide, as shown by immunoblotting. These results demonstrate that c-myc expression is an essential factor for proliferation of HSMCs after growth stimulation, and they show the potential of antisense technology for modulating gene expression of HSMCs in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1485890     DOI: 10.1007/bf00788668

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  31 in total

Review 1.  Antisense agents in pharmacology.

Authors:  B J Dolnick
Journal:  Biochem Pharmacol       Date:  1990-08-15       Impact factor: 5.858

2.  Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.

Authors:  P H Watson; R T Pon; R P Shiu
Journal:  Cancer Res       Date:  1991-08-01       Impact factor: 12.701

3.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

Authors:  M B Hansen; S E Nielsen; K Berg
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

4.  A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro.

Authors:  A M Gewirtz; B Calabretta
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

5.  Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc.

Authors:  L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.

Authors:  J T Holt; R L Redner; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

Review 8.  Restenosis after coronary angioplasty: an overview.

Authors:  R M Califf; D F Fortin; D J Frid; W R Harlan; E M Ohman; J R Bengtson; C L Nelson; J E Tcheng; D B Mark; R S Stack
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094

9.  Synthesis of DNA via deoxynucleoside H-phosphonate intermediates.

Authors:  B C Froehler; P G Ng; M D Matteucci
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

10.  Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.

Authors:  R M Burch; L C Mahan
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

View more
  6 in total

1.  Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.

Authors:  W Wang; H J Chen; A Schwartz; P J Cannon; C A Stein; L E Rabbani
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  Phosphorothioate Oligodeoxynucleotide Inhibition of Restenosis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

3.  The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.

Authors:  T L Burgess; E F Fisher; S L Ross; J V Bready; Y X Qian; L A Bayewitch; A M Cohen; C J Herrera; S S Hu; T B Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

4.  Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.

Authors:  M R Bennett; S Anglin; J R McEwan; R Jagoe; A C Newby; G I Evan
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

5.  Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?

Authors:  M R Bennett; T D Littlewood; D C Hancock; G I Evan; A C Newby
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

6.  Nucleolar stress induces a senescence-like phenotype in smooth muscle cells and promotes development of vascular degeneration.

Authors:  Wenjing Zhang; Wen Cheng; Rosanna Parlato; Xiaosun Guo; Xiaopei Cui; Chaochao Dai; Lei Xu; Jiankang Zhu; Min Zhu; Kun Luo; Wencheng Zhang; Bo Dong; Jianli Wang; Fan Jiang
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.